Skip to content

Walking for Health: an Intervention to Increase Physical Activity and Reduce Sedentary Behaviour in People With SMI

Walking for Health: The Feasibility of a Walking Intervention to Increase Physical Activity and Reduce Sedentary Behaviour in People With Severe Mental Illness

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04134871
Acronym
WORtH
Enrollment
54
Registered
2019-10-22
Start date
2019-08-22
Completion date
2022-12-31
Last updated
2023-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bipolar Disorder, Major Depression, Mental Illness, Psychosis, Schizophrenia

Brief summary

People who have a severe mental illness can have poorer physical health and higher mortality rates than the general population. Their medications combined with low levels of physical activity and increased sedentary behaviour can general population and may help people with severe mental illness to be more active. A previous feasibility study has been conducted in the UK in a large city with positive findings. The current study will be conducted in rural settings in Northern Ireland and Republic of Ireland. The intervention will last 13 weeks. People with Severe Mental Illness will be randomly assigned into one of two groups. Both groups will get information on the benefits of physical activity. In addition, one group will be shown how to use a step counter to measure their steps, be invited to a weekly group walk, and meet their coach every 2 weeks contribute to this. Walking is a good way to increase physical activity in the to see how they are getting on and to support them. The research team are interested in finding out how willing clinicians are to recruit people into the study, how willing people are to take part, do people then stick with the programme, and if not the reasons for people dropping out. Qualitative findings will explore whether participants feel they benefited from and enjoyed the programme. Findings will be used to investigate the feasibility to conduct a larger trial like this in the future.

Interventions

BEHAVIORALGroup walk and one to one coaching

Participants will be invited to attend a group education session, weekly group walks and fortnightly coaching sessions

Sponsors

University of Ulster
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Inactive adults (Male or Female; aged ≥18 years) * Diagnosis of any SMI (schizophrenia, psychosis, bipolar disorder and major depression).

Exclusion criteria

* Significant movement impairment * Identified as 'Active' using the GPPAQ screening tool * Unable to understand English or lack comprehension to understand the purpose of the study and given written informed consent.

Design outcomes

Primary

MeasureTime frameDescription
Study recruitment rateThrough study completion, approx. 18 monthsThe number of participants recruited to the study in relation to the number of individuals screened along with reasons for exclusion.
Retention of study participantsThrough study completion, approx. 18 monthsThe number of participants that complete the study intervention versus the number of dropouts will be analysed along with reasons for drop out.
Level of acceptability assessed by semi-structured interviewsData will be collected from participants at completion of the intervention, approx 3 months.Semi-structured interviews will involve gaining information on participants' level of overall satisfaction with the intervention

Secondary

MeasureTime frameDescription
Change in activity levelsData will be collected at baseline and at completion of intervention, approx 3 months.Participants' activity levels will be measured at baseline and end of intervention
Change in body weight (kilograms)Data will be collected at baseline and at completion of intervention, approx 3 months.Participants' body weight will be measured at baseline and end of intervention
Change in waist circumference (cm)Data will be collected at baseline and at completion of intervention, approx 3 months.Participants' waist circumference will be measured at baseline and end of intervention

Countries

Ireland, United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 9, 2026